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Background: Hafnium oxide, NBTXR3 nanoparticles were designed for high dose energy deposition within cancer
cells when exposed to ionizing radiation. The purpose of this study was to assess the possibility of predicting
in vitro the biological effect of NBTXR3 nanoparticles when exposed to ionizing radiation.
Methods: Cellular uptake of NBTXR3 nanoparticles was assessed in a panel of human cancer cell lines
(radioresistant and radiosensitive) by transmission electron microscopy. The radioenhancement of NBTXR3
nanoparticles was measured by the clonogenic survival assay.
Results: NBTXR3 nanoparticles were taken up by cells in a concentration dependent manner, forming clusters in
the cytoplasm. Differential nanoparticle uptake was observed between epithelial and mesenchymal or glioblastoma
cell lines. The dose enhancement factor increased with increase NBTXR3 nanoparticle concentration and radiation
dose. Beyond a minimum number of clusters per cell, the radioenhancement of NBTXR3 nanoparticles could be
estimated from the radiation dose delivered and the radiosensitivity of the cancer cell lines.
Conclusions: Our preliminary results suggest a predictable in vitro biological effect of NBTXR3 nanoparticles
exposed to ionizing radiation.Background
Ionizing radiation is a universal killer with ability to gen-
erate double strand breaks in the DNA; as such it is the
principle target for cancer cell killing. Ionizing radiation-
induced damage correlates with the energy dose depos-
ition in each biological structure [1]. As it is well-known
radiation always affects tissues surrounding the targeted
tumor and most often the dose, effective to control the
tumor, cannot be delivered due to damage to the sur-
rounding healthy tissues.
Recently, nanotechnologies have paved the way to new
approaches in local cancer therapy. Nanoparticles with
high electron density offer the possibility to deposit high
amounts of energy within the cancer cells when acti-
vated by ionizing radiation, providing appropriate bio-
availability and persistence [2,3].
Nanocrystals of hafnium oxide, NBTXR3 nanoparti-
cles, were designed for efficient cancer cell uptake and
interaction with different types of ionizing radiation. The* Correspondence: julie.marill@nanobiotix.com
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unless otherwise stated.high density material at the nanoscale and ionizing radi-
ation interactions render feasible the physical mode of ac-
tion of radiotherapy directly from within the cancer cells.
Using Monte Carlo calculation, activation of NBTXR3
nanoparticles with high energy photons (1 or 6 MeV)
already demonstrated a local energy deposit in specific
subcellular structures containing the nanoparticles [2].
Advancing this concept, we have implemented a global
in vitro research program to investigate if we could
predict the biological response of cells treated with
NBTXR3 nanoparticles exposed to ionizing radiation.
First, we estimated the nanoparticle uptake in a panel of
human cancer cell lines with increased nanoparticle con-
centration. Subsequently the NBTXR3 nanoparticle’s ef-
fect on cell survival was evaluated using the clonogenic
survival response curve. Our results suggest that above a
minimum number of nanoparticles per cell, the radioen-
hancement of NBTXR3 nanoparticles could be predicted
from the radiation dose delivered and the intrinsic radio-
sensitivity of the cancer cell line.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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NBTXR3 nanoparticles
NBTXR3 nanoparticles are functionalized hafnium oxide
(HfO2) crystallites, bearing a marked negative surface
charge in aqueous solution at pH 6-8. Specifically, the
studies reported in the present article were performed
with spherical nanoparticles with size and surface charge
of approximately 50 nm and -50 mV respectively (see
Additional file 1). NBTXR3 was used at increasing nano-
particle concentration from 50 μM up to 1600 μM.
Human cancer cell lines and culture conditions
The radiosensitive cell lines HCT 116 (colorectal carcin-
oma) and Hs913T (fibrosarcoma) were purchased from
the American Type Culture Collection (LGC Promochem,
Molsheim, France) and the Interlab Cell Line Collection
(Genova, Italy) respectively.
The radioresistant cell lines HT-29 (colorectal adeno-
carcinoma), FaDu (pharinx squamous cell carcinoma),
HT-1080 (fibrosarcoma) and PANC-1 (pancreas epithe-
lial carcinoma), were purchased from the American
Type Culture Collection (LGC). The radioresistant cell
lines NCI-H460-luc2 (non small cell lung adenocarcin-
oma) and CAL-33 (human head and neck squamous cell
carcinoma) were purchased from Caliper life science
(Villepinte, France). The radioresistant cell line 42-MG-
BA (glioblastoma multiforme), was purchased from the
Deutsche Sammlung von Mikroorganismen und Zelkul-
turen GmbH German Collection of Microorganism and
Cell Cultures (Braunschweig, Germany).
Cells were grown according to each manufacturer’s
recommendations (see Additional file 2). All cells lines
were kept in an incubator at 37°C under a 5% CO2 hu-
midified atmosphere.
Cellular uptake of NBTXR3 nanoparticle by Transmission
Electron Microscopy (TEM)
Cells were seeded into 6-well plates (in duplicate) at the
density of 20 000 cells/cm2. NBTXR3 nanoparticle con-
centrations from typically 50 μM up to 1600 μM were
tested. When cells were attached to the plate, NBTXR3
was added overnight (12 h-16 h) to the cells. Cells were
then pre-fixed with 2.5% glutaraldehyde in cacodylate
0.1 M at pH 7.4 (Sigma Aldrich, Saint Quentin Fallavier,
France) for 2 hours. Cells were subsequently post-fixed
with 1% osmium tetroxide (Sigma Aldrich) for 45 minutes,
washed and dehydrated in graded concentrations of ethanol
(50%, 70%, 95% and 100%) (Sigma Aldrich). Cell samples
were embedded with EPON (Oxford Instruments, Gometz
la Ville, France). The resin sample block was trimmed,
90 μm thin-sectioned to thickness of 70 nm, (diatome
diamond knives, Euromedex, Souffelweyersheim, France),
and collected on grids (Euromedex) for observation under
transmission electron microscopy (Zeiss, Omega 912,Service de Microscopie Electronique, IFR-83, Institut de
Biologie Integrative, UPMC, Paris, France). For each cell
line, a minimum of 20 cells were observed to estimate
NBTXR3 nanoparticles cell uptake. Parameters evaluated
included cluster number per cell and the cluster size. Size
was split between “small cluster” with a medium of size
around 0.45 μm of diameter and “large cluster” with a
diameter around 1.8 μm.
Evaluation of NBTXR3 nanoparticle effect on cells survival
by the clonogenic survival assay
Cells were seeded into 6-well plates (in triplicate) within
the range of 200 to 8000 cells/well. NBTXR3 nanoparti-
cles concentrations from typically 50 μM up to 800 μM
were tested. When cells were attached to the plate,
NBTXR3 was added overnight (12 h-16 h) to the cells
before delivering the radiation dose. The cells were cul-
tured with antibiotics (penicillin/streptomycin, Invitro-
gen) from 10 to 15 days at 37°C under a 5% CO2
humidified atmosphere, allowing cells to form colonies.
The colonies were fixed and stained with crystal violet
solution (Sigma Aldrich) and individual colonies were
counted using the standard procedure [4]. The Dose
Enhancement Factor (DEF) was calculated for each radi-
ation dose and each NBTXR3 nanoparticle concentra-
tion by taking the ratio of the surviving fractions of cells
exposed to radiation (no NBTXR3 treatment) and of
cells treated with NBTXR3 and exposed to radiation.
Three (3) independent experiments performed in tripli-
cate were pooled to calculate a mean surviving fraction
and standard deviation (SF mean ± SD (n = 3)) and mean
Dose Enhancement Factor (DEF mean ± SD (n = 3)).
Cell survival analysis
Cell survival curves were obtained by analysing the
mean surviving fractions (SF mean) with the linear
quadratic (LQ) model (Equation 1) using the GraphPad
Prism® V5.0 Software [5].
S ¼ e ‐ αDþβD2ð Þ½  ð1Þ
S represents the survival after radiation dose (D). α
(Gy−1) and β (Gy−2) are the linear and the quadratic pa-
rameters respectively.
Irradiation conditions
X-ray irradiations were delivered at dose rate of 1.26 Gy
min−1 using X-Ray generator (200 kV, 15 mA, 0.2 mm
Copper filtration, Institut Gustave Roussy, Villejuif, France).
The 6-well plates were irradiated with a single dose (0 Gy
(sham control) up to 4 Gy or 6 Gy) after incubation with
NBTXR3, and then replaced into the incubator until col-
onies formed.
Figure 2 NBTXR3 nanoparticles cellular uptake with increase of the NBTXR3 nanoparticle concentration. Cells were treated with
increasing doses of NBTXR3. Representative TEM images of HCT 116 cells treated with NBTXR3 400, 800 and 1600 μM and 42-MG-BA cells
treated with NBTXR3 50, 100 and 400 μM. Scale bars = 20 μm.
Figure 1 Semi quantitative analysis of NBTXR3 nanoparticles cellular uptake. Cells were treated with NBTXR3 overnight. (A) representative
TEM images (NBTXR3 400 μM) for mesenchymal (Hs913T, HT-1080), epithelial (HCT 116, HT-29, PANC-1) and glioblastoma (42-MG-BA) cells showing
clusters of nanoparticles in endosomes (black arrows) and (B) scatter plot and median value presenting the number of NBTXR3 nanoparticles’ clusters
per cell. Scale bars = 20 μm.
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In vitro exploration of NBTXR3 nanoparticle uptake in
human cancer cell lines
The cellular uptake of NBTXR3 nanoparticle at 400 μM
by epithelial (HCT 116, HT-29, PANC-1), mesenchymal
(Hs913T, HT-1080) and glioblastoma 42-MG-BA cell lines
was investigated by TEM (Figure 1A). NBTXR3 nanopar-
ticles have been shown to interact with cellular mem-
branes and to be taken up by cells (data not shown). Here,
TEM images showed NBTXR3 nanoparticles forming
clusters in the cytoplasm. Besides, the level of NBTXR3
nanoparticles taken up by cells depends on the specific cell
line. In the panel of human cancer cell lines tested, mesen-
chymal and glioblastoma cell lines seemed more likely to
uptake NBTXR3 nanoparticles when compared to epithe-
lial cell lines. Figure 1B presents the number of clusters of
NBTXR3 nanoparticles per cell for NBTXR3 concentra-
tion of 400 μM in HCT 116, HT-29, PANC-1, HT-1080,
Hs913T and 42-MG-BA cell lines. The number of clusters
varied between 8 and 114 (median 45), 4 and 87 (median
54), 63 and 185 (median 90) for the mesenchymal HT-Figure 3 Size of NBTXR3 nanoparticles’ clusters. Representative TEM im
(Bottom panel) treated with NBTXR3 100 μM. Scale bars = 1 μm (left panel)1080 and Hs913T and the glioblastoma 42-MG-BA cell
lines respectively. Clusters of NBTXR3 nanoparticles were
found in every cell observed. In contrast, the number of
clusters varied between 0 and 10 (median 2), 0 and 12
(median 0.5), 1 and 37 (median 18.5), for HCT 116, HT-
29 and PANC-1 epithelial cell lines respectively.
TEM images of the epithelial HCT 116 and glioblast-
oma 42-MG-BA cell lines, treated with increasing doses
of NBTXR3 are presented in Figure 2. The number of
clusters of NBTXR3 nanoparticles per cell increased
with increase of the NBTXR3 nanoparticle concentra-
tion. Furthermore, the size of NBTXR3 nanoparticles
clusters varied depending on the cancer cell line; as il-
lustrated in Figure 3, a larger size of clusters is observed
for the the glioblastoma 42-MG-BA model when com-
pared with the epithelial PANC-1 model.
In vitro assessment of NBTXR3 radioenhancement in a
panel of human cancer cell lines
Epithelial, mesenchymal and glioblastoma cancer cells, (ra-
diosensitive and radioresistant), were selected to evaluateages of NBTXR3 clusters in PANC-1 (Top panel) and 42-MG-BA cells
and 2 μm (right panel).
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NBTXR3 at increasing concentration and exposed to ioniz-
ing radiation (Figure 4 and Figure 5). The plating efficiency
of tested models was always superior to 20% (data not
shown). No clonogenic toxicity was observed under con-
tinuous incubation with NBTXR3 at increasing concentra-
tion in most cell lines in the panel. However, NBTXR3 at
300 μM and 800 μM showed IC50 in HT-1080 and
Hs913T cells lines respectively (data not shown).
Since, we believe the mode of action of NBTXR3
nanoparticles is to enhance dose rather than to sensitise
cells. Therefore we do not consider the term radiosensi-
tiser is appropriate in this situation. Analysis of the clo-
nogenic survival data shows that the DEF is a function
of dose. In order to analyse this dose dependence weFigure 4 In vitro assessment of NBTXR3 nanoparticles radioenhancem
of NBTXR3 nanoparticles overnight before being exposed to irradiation. Sym
simple linear regression.treat the DEF measurements in a slightly unusual way.
Rather than expressing the DEF at a given survival frac-
tion, e.g. DEF50, we determined the DEF as a ratio of
surviving fractions for a given radiation dose, i.e. for a
given radiation dose (D) we determined a survival frac-
tion in the presence of NBTXR3 nanoparticles, SF+NP
(D). We then determined for the same given radiation
dose (D) the survival fraction in the controls (i.e. without
nanoparticles), i.e. SF-NP(D). For a given radiation dose,
the DEF value was obtained by taking the ratio of the
two survival fractions, i.e. DEF = SF-NP(D)/SF+NP(D).
In the epithelial models (HCT 116, HT-29, PANC-1,
NCI H460-luc2), the measured mean DEF values (over the
triplicate measurements) ranged between 1.05 ≤DEF ≤
1.64 and 1.25 ≤DEF ≤ 2.63 for NBTXR3 (400 μM)ent. Human cancer cells were treated with increasing concentrations
bols represent the mean DEF. The data (mean DEF) were fitted by a
Figure 5 Cell survival curves. Human cancer cells were treated with increasing concentration of NBTXR3 nanoparticles overnight before being
exposed to radiation. Symbols represent mean surviving fraction (mean SF ± SD). The data (mean SF) were fitted with the LQ model equation to
estimate the α and β parameters.
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showed 1.21 ≤DEF ≤ 2.24 and 1.57 ≤DEF ≤ 5.09, activated
by 2 or 4 Gy respectively. For the mesenchymal and glio-
blastoma cell lines (HT-1080, Hs913T, 42-MG-BA), the
DEF values for NBTXR3 (400 μM) activated by 2 or 4 Gy
ranged between 1.57 ≤DEF ≤ 2.75 and 3.44 ≤DEF ≤ 5.36
respectively. The DEF values increased according to the
NBTXR3 concentrations and radiation dose (Figure 4). For
most of the tested cell lines the DEF was found to increase
linearly with NBTXR3 concentration and radiation dose.
Moreover, for the epithelial cancer cell lines HCT 116,
NCI-H460-luc2, PANC-1, the mesenchymal Hs913T, HT-
1080, and the glioblastoma 42-MG-BA cancer cell lines,
above a definite NBTXR3 concentration and radiation doseof 2 Gy, the DEF values were estimated using the equation 2
(Figure 6).
DEF XGyð Þ ¼ 0:5 X  DEF 2Gyð Þ ð2Þ
Equation 2 was applicable (i.e. the error between calculated
and observed DEF was less than 20%) for NBTXR3 concen-
tration≥ 800 μM in the epithelial cancer cells lines. Mean-
while, this equation was applicable at lower nanoparticle
concentrations, typically between 100 μM and 400 μM, in the
mesenchymal and glioblastoma cancer cell lines (Table 1 and
Figure 6). In addition, when equation 2 was applicable, the
DEF value observed at 2 Gy was correlated to the intrinsic ra-
diosensitivity (SF2) of the cell line (Table 1 and Figure 7).
Figure 6 Toward a predictive NBTXR3 nanoparticle radioenhancement. Calculated and measured DEF values in 42-MG-BA cell line with
increase NBTXR3 nanoparticles concentration and radiation dose and corresponding TEM images of NBTXR3 cell uptake. Scale bars = 20 μm.
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dose
The parameters associated with the survival curves are
summarized in Table 2. For each cell line tested, the lin-
ear parameter α increased with increased nanoparticleTable 1 Toward a predictive NBTXR3 nanoparticle radioenhan
Onset of NBTXR3 nanopartic
Cell line SF2 (mean ± SD) [NBTXR3] μM (
HCT 116 22.4 (±9.14) 800
Hs913T 25.2 (±2.27) 400
NCI H460-Luc2 36.0 (±3.2) 800
42-MG-BA 37.3 (±2.53) 200
HT-1080 38.9 (±1.39) 100
PANC-1 40.6 (±6.64) 800
CAL-33 64.8 (±2.12) nd
FaDu 66.0 (±6.78) nd
Onset of NBTXR3 nanoparticles concentrations where equation 2 predicts an observ
DEF values at 2 Gy. nd: non determined.concentration. For control cell lines (radiation alone), α
ranged between 0.05 Gy−1 and 0.68 Gy−1 and reflected the
radiosensitivity of each cell line (see SF2 values), whereas
cells treated with NBTXR3 at 400 μM and exposed to
ionizing radiation, alpha ranged between 0.43 Gy−1 andcement
les concentration where equation 2 predicts an observable effect









able effect are presented together with the corresponding measured mean
Figure 7 Mean DEF at 2 Gy as a function of cell line radiosensitivity. The reported mean DEF values at 2 Gy correspond to the onset of
NBTXR3 concentration where equation 2 predicts an observable effect, and depend of the intrinsic radiosensitivity (SF2) of the cell line, see
Table 1.
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and NBTXR3 treated cell lines, ranged between 0.01 Gy−2
and 0.09 Gy−2.
We established an effective survival curve model in
the context of fractionated radiotherapy (2 Gy) once
daily, for 25 days, for the fibrosarcoma cell lines exposed
to 400 μM of NBTXR3, and compared the results of this
model to corresponding predictions for radiotherapy
alone. We assumed that the window between successive
fractions has allowed the physiological repair (sublethal
damage) in cells. The α and β parameters using the LQ
model for the HT-1080 and Hs913T cell lines with
NBTXR3 concentration of 400 μM and using the X-ray
generator 200 kVp, were used in this simulation (Figure 8).
From these data, it could be calculated that a total dose ofTable 2 Radiobiological parameters for each cell line exposed
nanoparticles
Cell line SF2 values (mean ± SD) Control
50 μM
α β α β
42-MG-BA 37.3 (±2.53) 0.45 0.02 0.47 0.02
HCT 116 22.4 (±9.14) 0.54 0.08† 0.58 0.08†
PANC-1 40.6 (±6.64) 0.43 0.01 0.41 0.02
HT-1080 38.9 (±1.39) 0.33 0.06 0.37 0.07
Hs913T 25.2 (±2.27) 0.68 0.83
HT-29 54.1 (±9.50) 0.28 0.05 0.30 0.05
FaDu 66.0 (±6.78) 0.12 0.06 nd nd
CAL-33 64.8 (±2.12) 0.05 0.08 nd nd
The LQ model was used to fit the surviving fraction data using GraphPad Prism® V5
improve the quality of the fit. The SF2 value for each cell lines is reported.approximately 29 Gy and 17 Gy was necessary to eradicate
109 HT-1080 and Hs913T cells respectively (which is
about equivalent to the number of cells in a tumor of ap-
proximately 1 cm3) with presence of NBTXR3 nanoparti-
cles, whereas a total dose of approximately 45 Gy and
30.5 Gy respectively was necessary for the same outcome
in these cell lines with radiotherapy alone.
Discussion
Uptake of NBTXR3 by cancer cells
Cellular uptake of nanoparticles depends on many fac-
tors, including nanoparticles size, shape, and compos-
ition of the protein corona [6-10]. Some studies have
reported saturation of nanoparticle uptake within hours
[11], whereas others after several days [12].to radiation with increased concentration of
[NBTXR3]
100 μM 200 μM 400 μM 800 μM
α β α β α β α β
0.48 0.03 0.54 0.03 0.57 0.05 0.60 0.05
0.60 0.08† 0.68 0.08† 0.74 0.08† 0.84 0.08†
0.44 0.02 0.50 0.01 0.50 0.02† 0.51 0.02†
0.44 0.08 nd nd 0.55 0.07 nd nd
0.99 1.07 1.2 1.38
0.39 0.03 0.40 0.03 0.43 0.05† 0.46 0.05†
0.26 0.04 nd nd 0.31 0.06 0.28 0.09
0.08 0.08 nd nd 0.16 0.07 0.16 0.09
.0 Software, extracting α and β parameters. †: β value was constrained to
Figure 8 “Effective” survival curve. An effective survival curve was established for radioresistant HT-1080 and Hs913T cell lines, in the context
of fractionated radiotherapy, 2 Gy per fraction, delivered once daily for 25 days, with presence of NBTXR3 nanoparticles (400 μM), and compared
with radiotherapy alone control (arrow indicate the BED).
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was influenced by the cell cycle phase with quantities of
nanoparticles per cell being ranked according to G2/M >
S > G0/G1 [13].
The cellular uptake of plasma membrane receptors
mediated by clathrin is used by all known eukaryotic
cells and is involved in many key cellular functions [14].
The pathway is exploited by toxins, viruses and bacteria
to effect entry into cells. In epithelial cells, the size of
clathrin-coated vesicles has been found to depend on
the size of its cargo [15] with an observed upper limit of
about 200 nm for virus uptake [16]. In mesenchymal
stem cells, Huang et al. showed that phagocytosis and
pinocytosis were the main courses of endocytosis for
non-specific uptake of nanoparticles [17]. Also, many
cancer cells (the most aggressive) have been described
with phagocytic properties both in vitro and in vivo [18].
Here, we presented a clear trend for differential
NBTXR3 nanoparticles’ uptake between epithelial and
mesenchymal or glioblastoma cell lines, both in terms of
number and size of clusters per cell. Extensive studies
have already revealed differential NBTXR3 nanoparticles
uptake according to the specificity of the cell line, for in-
stance, fibrosarcoma cells were shown to capture more
than fibroblast cells even if they share the same cell ori-
gin (data not shown). The exact mechanism for this dif-
ferential uptake deserves more studies and is beyond the
objectives of this paper.
Effect of NBTXR3 nanoparticles on the biological effective
dose
Radiation dose deposit within any tissue sample is linked
to its ability to absorb/interact with x-rays. Introductionof material with a high electron density into the x-ray
pathway can increase absorption as compared with
water. Only the use of such material at the nanoscale
can bring the physical mode of action of radiotherapy
from within the cancer cells. Local dosimetry at the
cellular level has yielded evidence of increased deposit
of energy in specific subcellular structures containing
the high electron density nanoparticles, via secondary
electron emission (photoelectric and/or Compton effect),
photon emission and also possibly via characteristic
x-ray photon, Auger cascade and subsequent radical pro-
duction. In addition, significant in vitro radioenhancement
has already been reported to be related to the nanoparti-
cles location at the subcellular level [2,3,19].
The Linear Quadratic model assumes that lethal radi-
ation damage, as a result of double-strand breaks in the
DNA, is created either as a consequence of a single
ionizing event or as a consequence of two separate sub-
lethal ionizing events that interact pairwise to create
lethal damage [20]. α and β parameters are considered
to be measures of the probability of inducing damage
following a single or two separate sublethal ionizing
events respectively [4,21]. In the panel of human cancer
cell lines tested, the survival curves fitted using the LQ
model showed that the α and not the β parameter, was
systematically increased in cells treated with increasing
concentrations of NBTXR3 exposed to 200 kVp photon
beam, when compared to the radiation control (Table 2).
These findings confirmed the expectation that higher
energy dose deposition within the cancer cell increases
the probability of cell killing. Concerning the impact of
NBTXR3 nanoparticles on the β parameter value, no ef-
fect was observed.
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gesting that dose fractionation (daily fractions of 2 Gy)
increases survival and decreases late toxicity as com-
pared to a single equivalent dose. Tumors in contrast have
high alpha-beta ratios and do not benefit from fractionation.
The radiation tolerance dose is generally expressed quanti-
tatively in terms of the biologically effective dose (BED), as
defined by the LQ model. BED is the total dose required
to obtain an equal biological effect for a certain endpoint,
such as a given log cell kill. In presence of NBTXR3 nano-
particles, we estimated a decrease of the BED (see black
arrows in Figure 8) which may be correlated with an in-
crease of the α parameter in these cancer cell lines.
Toward a predictive in vitro radioenhancement of
NBTXR3 nanoparticles in human cancer cell lines?
Radioenhancement of NBTXR3 nanoparticles in all tested
human cancer cell lines was found to increase with both
NBTXR3 nanoparticle concentration and radiation dose.
For the following cancer cell lines, HCT 116, NCI-H460-
luc2, PANC-1, Hs913T, HT-1080, and 42-MG-BA, above
a certain nanoparticle concentration and 2 Gy, equation 2
predicted an observable effect. According to equation 2,
for a radiation dose (D) of 2 Gy and more, the DEF values
were found to vary linearly with the dose D (i.e. the DEF
value was equal to the DEF value at 2 Gy multiplied by the
extra quantity of radiation dose 0.5 × X Gy). The nanopar-
ticles concentration was dependent on the cell line. For
the epithelial cancer cell lines, a minimum NBTXR3
concentration of 800 μM was necessary, whereas in the
mesenchymal and glioblastoma cancer cell lines a lower
nanoparticle concentrations, typically between 100 μM
and 400 μM, was needed. The NBTXR3 nanoparticles cell
uptake was related to some extent to the biological behav-
ior of each cancer cell line. For instance, in the 42-MG-BA
model, a marked uptake was seen in all the observed cells
at the low NBTXR3 concentration of 100 μM, whereas for
HCT 116 cells it was observed at 800 μM or above (see in
Figure 2). Of note, in vitro NBTXR3 cellular uptake was
observed to be lower in CAL-33 and FaDu cell lines at
NBTXR3 concentration 800 μM (data not shown).
These results suggest that in vitro, a minimum quan-
tity of nanoparticles in the cell – i.e. a minimum number
of NBTXR3 nanoparticles clusters per cell – may be re-
quired to predict an observable effect, whatever the can-
cer cell line.
Monte Carlo calculations have demonstrated that
NBTXR3 nanoparticles locally enhance the radiation
dose deposit when exposed to ionizing radiation [2].
Here we show in vitro that activation of NBTXR3 nano-
particles from within the cancer cells by 200 kVp X-rays,
triggers a biological response which seems correlated to
the inherent radiosensitivity of the cancer cell line and
also to the radiation dose delivered.Conclusion
In the panel of human cancer cell lines tested, a differen-
tial NBTXR3 nanoparticles cell uptake was observed be-
tween epithelial and mesenchymal or glioblastoma cell
lines. Other characteristics such as the aggressive behav-
ior of the cancer cells may also be considered. Besides,
the clonogenic survival curves showed an increase of the
α parameter, i.e. a decrease of the BED, with increasing
NBTXR3 nanoparticles concentration.
Interestingly, while Monte Carlo calculations have already
demonstrated marked radiation dose enhancement where
NBTXR3 nanoparticles are, we showed in vitro that the
biological response of the cancer cells treated with NBTXR3
nanoparticles and exposed to ionizing radiation may be an-
ticipated from the intrinsic radiosensitivity of the cancer cell
line and the radiation dose delivered. In the future, more
cancer cells lines should be evaluated to confirm these
promising results.Additional files
Additional file 1: NBTXR3 nanoparticles. NBTXR3 nanoparticles
hydrodynamic diameter and a polydispersity index (about 50 nm and
0.100, respectively) were determined by dynamic light scattering
technique (Zetasizer NanoZS, Malvern Instruments Ltd, Worcestershire,
UK). The surface charge of the nanoparticles in aqueous solution at pH
values between 6 and 8 (about -50 mV) was estimated by zeta potential
analysis (Zetasizer NanoZS). Spherical nanoparticle shape was determined
using transmission electron microscopy technique (JEOL JEM 100CX
operating at 100 kV, Service de Microscopie Electronique, UMR 7197,
UPMC, Paris, France).
Additional file 2: Human cancer cell lines and culture conditions.
The HCT 116 and HT-29 cells were grown in McCoy’s 5a medium
(Invitrogen, Fisher scientific, Illkirch, France), supplemented with 10%
(v/v) of heat-inactivated fetal calf serum (FCS) (Invitrogen). The NCI-H460-luc2
cells were grown in Dulbecco’s Modified Eagle’s Medium (DMEM) with
GlutaMAX™ medium (Invitrogen), supplemented with 10% of FCS (PAA,
Velizy-Villacoublay, France). The PANC-1, HT-1080, CAL-33 and Hs913T cells
were grown in DMEM with GlutaMAXTM (Invitrogen), supplemented with
10% of inactivated FCS (Invitrogen). The 42-MG-BA cells were grown in
DMEM with GlutaMAXTM (Invitrogen) and Minimum Essential Media (MEM)
(1:1) (Invitrogen), supplemented with 10% FCS (Invitrogen). The FaDu cells
were grown in MEM with GlutaMAXTM (Invitrogen), supplemented with 10%
FCS (Invitrogen). All cells lines were kept in an incubator at 37°C under 5%
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